---
created: 2025-04-13
updated: 2025-04-13T10:51
id: Mg.P2.~Q}j
specialty: neuro
specialty_id: 109
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::05-insomnia-therapy::suvorexant
  - source/ak-step1-v11::
  - source/ome-banner
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::14-neuro::07-suvorexant
  - source/ak-step1-v11::
  - theme/pixorize::03-pharm::15-other-neuro::suvorexant
  - source/ak-step1-v11::
  - theme/sketchypharm::06-neuro/psych::01-sedative-hypnotics::02-nonbenzodiazepine-hypnotics,-melatonin,-ramelteon
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield
  - source/ak-step1-v11::^systems::neuro::pharmacology"
type: flashcard
---

# Question
Suvorexant is contraindicated in patients taking strong **CYP3A4** inhibitors

---

# Answer
